|
CCDC132 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.372460E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.240370E-02 |
| Normal-vs-Stage2 |
3.979000E-01 |
| Normal-vs-Stage3 |
4.372500E-04 |
| Normal-vs-Stage4 |
6.176100E-04 |
| Stage1-vs-Stage2 |
7.159000E-01 |
| Stage1-vs-Stage3 |
6.592300E-02 |
| Stage1-vs-Stage4 |
3.161400E-01 |
| Stage2-vs-Stage3 |
1.235020E-01 |
| Stage2-vs-Stage4 |
2.416800E-01 |
| Stage3-vs-Stage4 |
9.644400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.160200E-02 |
| Normal-vs-AfricanAmerican |
1.530490E-02 |
| Normal-vs-Asian |
9.560200E-01 |
| Caucasian-vs-AfricanAmerican |
3.910600E-01 |
| Caucasian-vs-Asian |
6.220800E-01 |
| AfricanAmerican-vs-Asian |
4.046200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.134090E-02 |
| Normal-vs-Female |
1.923180E-01 |
| Male-vs-Female |
5.736000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.803700E-03 |
| Normal-vs-Extreme_Weight |
2.242200E-02 |
| Normal-vs-Obese |
6.203600E-02 |
| Normal-vs-Extreme_Obese |
4.957800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.671400E-01 |
| Normal_Weight-vs-Obese |
3.218800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.375800E-01 |
| Extreme_Weight-vs-Obese |
7.729800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.391200E-01 |
| Obese-vs-Extreme_Obese |
9.486200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.505790E-01 |
| Normal-vs-Age(41-60Yrs) |
5.170000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.844110E-03 |
| Normal-vs-Age(81-100Yrs) |
5.514300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.274800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.303600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.195400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.365800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.250000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.341800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.989400E-01 |
| Normal-VS-Type2 PRCC |
5.76190000000087E-05 |
| Normal-VS-KIRP CIMP |
1.870450E-02 |
| Normal-VS-Unclassified PRCC |
3.687200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.16229999999906E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.673700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.304000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.439200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.624000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.009800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.162900E-04 |
| Normal-vs-N1 |
3.824800E-03 |
| Normal-vs-N2 |
9.608900E-04 |
| N0-vs-N1 |
8.363400E-01 |
| N0-vs-N2 |
3.630400E-01 |
| N1-vs-N2 |
4.193000E-01 |
|
|
